Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Department of Biobehavioral Nursing and Health Informatics, University of Washington, Seattle, WA, USA.
Subst Use Addctn J. 2024 Jul;45(3):423-433. doi: 10.1177/29767342241227402. Epub 2024 Feb 7.
The relationships between opioid use disorder (OUD), chronic pain, and mental health distress are complex and multidirectional. The objective of this exploratory study was to examine the relationship between mental health conditions and Chronic pain severity and interference among patients stabilized on either buprenorphine or methadone.
We report baseline data from a randomized trial of a mind-body intervention conducted at 5 outpatient clinics that provided either buprenorphine or methadone treatment. Validated scales were used to measure substance use, mental health distress, and pain severity and interference. Statistical analyses examined the relationship between mental health conditions and pain severity and interference.
Of 303 participants, 57% (n = 172) reported Chronic pain. A total of 88% (n = 268) were prescribed buprenorphine. Mental health conditions were common, with one-quarter of the sample screening positive for all 3 mental health conditions (anxiety, depression, and posttraumatic stress disorder [PTSD]). Compared to participants without Chronic pain, participants with Chronic pain were more likely to screen positive for moderate-severe anxiety (47% vs 31%); moderate-severe depression (54% vs 41%); and the combination of anxiety, depression, and PTSD (31% vs 18%). Among participants with Chronic pain, mental health conditions were associated with higher pain interference. Pain severity was higher among participants with mental health conditions, but only reached statistical significance for depression. Pain interference scores increased with a higher number of co-occurring mental health conditions.
Among individuals stabilized on either buprenorphine or methadone, highly symptomatic and comorbid mental health distress is common and is associated with increased pain interference. Adequate screening for, and treatment of, mental health conditions in patients with OUD and Chronic pain is needed.
阿片类药物使用障碍(OUD)、慢性疼痛和心理健康困扰之间的关系复杂且相互关联。本探索性研究的目的是检查心理健康状况与慢性疼痛严重程度和接受丁丙诺啡或美沙酮稳定治疗的患者的疼痛干扰之间的关系。
我们报告了在提供丁丙诺啡或美沙酮治疗的 5 家门诊诊所进行的身心干预随机试验的基线数据。使用经过验证的量表来衡量物质使用、心理健康困扰和疼痛严重程度和干扰。统计分析检查了心理健康状况与疼痛严重程度和干扰之间的关系。
在 303 名参与者中,57%(n=172)报告有慢性疼痛。共有 88%(n=268)接受了丁丙诺啡处方。心理健康状况很常见,四分之一的样本筛查出所有 3 种心理健康状况(焦虑、抑郁和创伤后应激障碍 [PTSD])呈阳性。与没有慢性疼痛的参与者相比,有慢性疼痛的参与者更有可能出现中度至重度焦虑(47%对 31%);中度至重度抑郁(54%对 41%);以及焦虑、抑郁和 PTSD 的组合(31%对 18%)。在有慢性疼痛的参与者中,心理健康状况与更高的疼痛干扰有关。有心理健康状况的参与者的疼痛严重程度更高,但仅在抑郁方面达到统计学意义。疼痛干扰评分随着同时存在的心理健康状况数量的增加而增加。
在接受丁丙诺啡或美沙酮稳定治疗的个体中,高度症状和共病性心理健康困扰很常见,并且与疼痛干扰增加有关。需要对患有 OUD 和慢性疼痛的患者进行充分的心理健康状况筛查和治疗。